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Petection of Coronary
rtery Disease in Asymptomatic
atients With Type 2 Diabetes Mellitus
oldano Scognamiglio, MD,* Christian Negut, MD,* Angelo Ramondo, MD,† Antonio Tiengo, MD,*
ngelo Avogaro, MD*
adua, Italy
OBJECTIVES We sought to verify the effectiveness of current American Diabetes Association screening
guidelines in identifying asymptomatic patients with coronary artery disease (CAD) in type
2 diabetes mellitus (DM2).
BACKGROUND In DM2 patients, CAD generally is detected in an advanced stage with an extensive
atherosclerosis and poor outcome, whereas CAD in an asymptomatic stage is commonly
missed.
METHODS This study included 1,899 asymptomatic DM2 patients (age 60 years). Of these, 1,121 had
2 associated risk factors (RFs), group A, and the remaining 778 had 1 RF, group B, for
CAD. All patients underwent dipyridamole myocardial contrast echocardiography (MCE),
and in those with myocardial perfusion defects, the anatomy of coronary vessels was analyzed
by selective coronary angiography.
RESULTS In the two study groups, the prevalence of abnormal MCE (59.4% vs. 60%, p  0.96) and
of a significant CAD (64.6% vs. 65.5%, p  0.92) was similar, irrespective of RF profile. But
coronary anatomy differed: group B had a lower prevalence of three-vessel disease (7.6% vs.
33.3%, p  0.001), of diffuse disease (18.0% vs. 54.9%, p  0.001), and of vessel occlusion
(3.8% vs. 31.2%, p 0.001), whereas one-vessel disease was more frequent (70.6% vs. 46.3%,
p 0.001). Coronary anatomy did not allow any revascularization procedure in 45% of group
A patients.
CONCLUSIONS An “aggressive” diagnostic approach, requiring coronary angiography in asymptomatic DM2
patients with 1 associated RF for CAD and abnormal MCE, identified patients with a
subclinical CAD characterized by a more favorable angiographic anatomy. The criterion of
2 RFs did not help to identify asymptomatic patients with a higher prevalence of CAD and
is only related to a more severe CAD with unfavorable coronary anatomy. (J Am Coll
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.10.008Cardiol 2006;47:65–71) © 2006 by the American College of Cardiology Foundation
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oiabetes is an important risk factor for the development of
AD (1). It has been estimated that 75% of the deaths in
iabetic patients may be attributed to CAD (2). Patients
ith diabetes develop CAD at an accelerated rate and have
higher incidence of heart failure, myocardial infarction,
nd cardiac death than their nondiabetic counterparts (3). In
eneral, CAD in diabetic patients is detected in an advanced
tage, whereas the disease in its premature, asymptomatic
tages remains unfortunately undetected (4). As a conse-
uence, diabetic patients have a more extensive coronary
therosclerosis and their epicardial vessels are less amenable
o interventional treatment compared with the nondiabetic
opulation (5–7). Moreover, compared with nondiabetic
atients, diabetic subjects have lower ejection fraction and
ore frequent silent myocardial infarction (8–13). These
ndings might easily explain the poor outcome of these
atients. Such observations impose an aggressive approach
o diagnostic strategies in diabetic patients to detect CAD
n an early asymptomatic stage, which is probably charac-
erized by a more favorable coronary vessel anatomy and by
From *Metabolic Cardiology, Division of Metabolic Diseases, and the †Division of
ardiology, Department of Clinical and Experimental Medicine, University of Padua
edical School, Padua, Italy.m
Manuscript received May 16, 2005; revised manuscript received August 1, 2005,
ccepted August 2, 2005.he absence of significant myocardial complications. The
onsensus Development Conference on the diagnosis of
AD in people with diabetes of the American Diabetes
ssociation (ADA) (14) recommends performing stress
creening for CAD in asymptomatic patients with two or
ore additional risk factors (RFs). It was stated that
symptomatic diabetic patients with 1 RF do not require
ardiac testing. These indications were not on the basis of
linical data, which are lacking, but rather on the personal
udgments and consensus of experts.
In the present study, including a large population of adult
age 60 years) asymptomatic patients with type 2 diabetes
ellitus (DM2), we used a diagnostic approach of a
oronary angiogram after the demonstration of myocardial
erfusion defects by stress myocardial contrast echocardiog-
aphy (MCE), which has been shown to accurately assess
ow-limiting coronary artery stenosis during vasodilator
ests (15,16). Each patient completed the diagnostic se-
uence irrespective of the RF profile. The purpose was to
erify the effectiveness of current ADA screening guidelines
n identifying asymptomatic patients with CAD. These
uidelines are on the basis of the assumption (never previ-
usly demonstrated) that asymptomatic DM2 patients with
ore RFs are more likely to have significant CAD than
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CAD in Diabetes Mellitus January 3, 2006:65–71hose with fewer RFs and, thus, more likely to have
bnormal stress imaging abnormalities. Furthermore, we
nvestigated whether the aggressive diagnostic approach
roposed in this study has the same capacity of identifying
symptomatic patients with significant CAD, with the
dvantage of detection in a phase with a more favorable
ngiographic anatomy that might render the coronary ves-
els more amenable to interventional treatment.
ETHODS
atients and study design. The population of the province
f Padua is served by a unified medical care system that has
ccumulated comprehensive records over a long period of
ime and has a relatively high diabetes mellitus prevalence.
ach care unit for diabetic patients in the country uses a
edical record system whereby all data are assembled in one
lace (Diabetes Care Unit of Padua University). For this
tudy, all consecutive diabetic patients who had a follow-up
isit in the first three-month period of 2003 were included.
he flow chart of the study population is depicted in Figure
. This prospective study enrolled 2,437 consecutive,
Abbreviations and Acronyms
ADA  American Diabetes Association
beta  rate constant
CABG coronary artery bypass grafting
CAD  coronary artery disease
CVD  cardiovascular disease
DM2  type 2 diabetes mellitus
HbA  hemoglobin
LAD  left anterior descending coronary artery
LCX  left circumflex coronary artery
MBF  myocardial blood flow
MCE  myocardial contrast echocardiography
MBV  myocardial blood volume
PCI  percutaneous coronary intervention
RF  risk factorFigure 1. Flow chart ofsymptomatic patients with DM2 (age 60 years). Forty-
wo patients refused to participate, and 449 were excluded
ecause they have angina pectoris or anginal-equivalent
ymptoms or a previous history of angina subsequently
esolved. To exclude patients with high risk of complica-
ions during dipyridamole stress, established CAD, or
ntities potentially associated with perfusion defects, the
ollowing exclusion criteria were adopted: 1) previous his-
ory of bronchial asthma precluding the use of dipyridamole;
) history of documented myocardial infarction; 3) electro-
ardiographic evidence of Q-wave myocardial infarction,
schemic ST-segment, or T-wave changes; 4) prior percu-
aneous coronary intervention or coronary artery bypass
rafting; 5) technically suboptimal contrast echocardio-
raphic images; and 6) clinically significant valvular heart
isease or cardiomyopathy. On the basis of these criteria, 47
atients were excluded.
At the beginning of the study, the RFs considered were
hose outlined in 1998 by Consensus Statement of the ADA
14). The targets for these RFs were subsequently re-
valuated after the publication of the last (2005) Position
tatement in Standards of medical care in diabetes (17) (i.e.,
ow-density lipoprotein [LDL] cholesterol 100 mg/dl or
igh-density lipoprotein [HDL] cholesterol 40 mg/dl,
lood pressure130/80 mm Hg, smoking, family history of
remature CAD [defined by ascertained critical epicardial
oronary atherosclerosis, sudden cardiac death with coronary
therosclerosis at autopsy, or myocardial infarction in a family
ember younger than 45 years in men and younger than 55
ears in women], and positive micro/macroalbuminuria),
hereas criteria to indicate a stress test to detect silent CAD
emain unchanged (14). Statistical analysis of data collected did
ot show significant differences in any of the evaluated hypoth-
ses independently on the criteria used (ADA, 1998 vs. 2005).
ence, we referred the results derived only from data analysis
btained in light of 2005 ADA standards of care (17).study population.
h
p
c
n
c
c
o
w
i
c
d
e
s
t
t
a
t
m
u
(
m
a
(
d
p
c
s
i
s
p
e
0
o
s
w
p
t
u
p
i
b
2
a
i
E
d
i
f
h
P
f
m
C
S
i
S
m
i
w
l
s
o
s
w
a
e
t
w
D
o
t
p
e
d
m
s
t
M
fl
c
a
b
t
M
w
o
a
a
o
m
b
C
w
c
p
g
i
s
d
i
b
g
a
A
s
m
S
67JACC Vol. 47, No. 1, 2006 Scognamiglio et al.
January 3, 2006:65–71 CAD in Diabetes MellitusBefore performing standard echocardiography, all patients
ad a venous blood sample for determination of the following
arameters: hemoglobin (HbA), total, LDL- and HDL-
holesterol, triglycerides, glycemia, potassium, sodium, creati-
ine, aspartate-aminotransferase, alanine-aminotransferase,
reatine phosphokinase, and HbA1c. Other RFs for cardiovas-
ular disease (CVD) were evaluated by history-taking. Values
f other demographic parameters (age, gender, height/
eight, and body mass index) at the moment of enrollment
n the study were evaluated by searching the ambulatory
linical database. The presence/absence of retinopathy was
ocumented both by a detailed and comprehensive eye
xamination and by the acquisition of high-quality stereo-
copic photographs assessed by an ophthalmologist. Pa-
ients were tested for diabetic neuropathy (sensation to
ouch by monofilament, vibration sensation by tuning fork,
nd Achilles tendon reflex) and cardiac autonomic dysfunc-
ion (heart rate changes during deep breathing, the Valsalva
aneuver, from lying to standing). Nephropathy was doc-
mented by the measurement of urinary albumin excretion
UAE): microalbuminuria was defined as UAE 30 g/
in in at least three successive measurements, in the
bsence of other factors capable of causing proteinuria
urinary infection, glomerulonephritis, kidney stone, blad-
er cancer, etc.). Moreover, to document the possible
resence of macrovascular disease, each subject was carefully
haracterized in terms of regional manifestations of athero-
clerosis. A complete lifestyle questionnaire to obtain med-
cal histories, parental history of CVD, information on
moking habits, and physical activity was filled in by the
atients and individually checked. Peripheral vascular dis-
ase was considered if the ankle-brachial pressure index was
.9 or less. A Doppler ultrasound of the carotid arteries was
btained in each patient to exclude significant carotid
tenosis (50% luminal narrowing).
Finally, the study population consisted of 1,899 patients
ho were divided on the basis of the major RFs. Of these
atients, 1,170 (62%) had 2 RFs for CAD (group A), and
he remaining 729 had 1 RF for CAD (group B).
To detect myocardial perfusion abnormalities, all patients
nderwent a pharmacologic stress myocardial perfusion
rotocol including MCE at rest and during dipyridamole
nfusion. All DM2 patients with perfusion defects detected
y MCE underwent coronary angiography at a mean of 9
days after the noninvasive test. The study protocol was
pproved by the Ethical Committee of our University, and
nformed consent was obtained from all participants.
chocardiographic analysis. Myocardial contrast echocar-
iography was performed at rest and during dipyridamole
nfusion (0.84 mg/kg body weight over 6 min), in apical
our-, two-, and three-chamber view using an intermittent
armonic imaging with a phased-array system (Sonos 5500,
hilips Medical System, Andover, Massachusetts) inter-
aced to an S3 transducer that transmits ultrasound at a
ean frequency of 1.6 MHz and receives it at 3.2 MHz.
ontinuous venous infusion of a contrast agent (Levovist, wchering AG, Berlin, Germany) was performed with an
nfusion pump (Medrad Pulsar, Indianola, Pennsylvania).
ignal intensity was measured by acoustic densitometry in
yocardial regions of the left ventricle and in the cavity. An
ntensity versus dose curve from the left ventricular cavity
as plotted to obtain the dose where the relationship was
inear. This dose was used in the contrast echocardiographic
tudies. Absence of any change in myocardial video intensity
ver five successive frames by visual assessment indicated the
teady state. Once steady state was achieved, repeat imaging
as obtained with sequential electrocardiogram triggering
t end-systole. The pulsing interval was gated to the
lectrocardiograph and progressively increased from 80 ms
o 10 s. Up to 12 images, acquired at each pulsing interval,
ere recorded on optical disk for quantitative analysis.
igitized studies were coded and read by two independent
bservers blinded to the patient’s identity and the order of
he study.
Background-subtracted myocardial signal intensity was
lotted over the increasing pulsing intervals and fit to an
xponential function as described by Wei et al. (18) for the
etermination of the rate constant (beta), which provides a
easure of flow velocity, and the myocardial plateau inten-
ity, which correlates with capillary cross sectional area and
o myocardial blood volume (MBV). The product (beta 
BV) represents a dimensionless index of myocardial blood
ow (MBF) (19). During dipyridamole infusion, the myo-
ardium subtended by 50% coronary stenosis shows an
ttenuated hyperemic response (20), and both MBF and
eta reserve decrease, as compared with myocardium sub-
ended by no stenosis (21). Thus, MBF reserve (stress
BF/rest MBF) and beta reserve (stress beta/rest beta)
ere calculated. These parameters allow accurate detection
f patients with CAD. A perfusion defect during dipyrid-
mole infusion was diagnosed when MBF reserve was 1
nd/or beta reserve 1.5 (15,16). In this study, the degree
f interobserver and intraobserver correlations for measure-
ents of MBV (r  0.94 and r  0.96, respectively) and
eta (r  0.95 and r  0.96, respectively) was acceptable.
oronary angiography. Selective coronary angiography
as performed with the standard Judkins approach. All
oronary angiograms were interpreted by two experienced
hysicians who were unaware of the contrast echocardio-
raphic perfusion results. No cardiac events occurred in the
nterval between myocardial contrast echocardiographic
tudy and coronary angiography. Significant CAD was
efined as the presence of 50% luminal diameter narrow-
ng of one or more major epicardial arteries or its major
ranches. For CAD location, left main stenosis was re-
arded as disease of the left anterior descending coronary
rtery (LAD) and the left circumflex coronary artery (LCX).
“diffuse disease” was defined by the presence of significant
tenosis in 2 coronary vessels with stenosis in 2 seg-
ents of each vessel.
tatistical analysis. Descriptive statistics were generated
ith percentages for discrete variables and mean  SD for
n
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CAD in Diabetes Mellitus January 3, 2006:65–71ormally distributed continuous variables. Continuous vari-
bles were compared between groups by means of the
wo-sample t test. A multivariate Cox proportional hazard
egression model was used to determine if clinical charac-
eristics were independently associated with significant
AD at coronary angiography. Regression analysis was
erformed for the major RFs (smoking, arterial hyperten-
ion, hypercholesterolemia, family history of premature
AD), body mass index (BMI), HbA1c, duration of diabe-
es, retinopathy, and PVD. The number of coronary vessels
nd the presence of occlusion and of a “diffuse” disease were
ompared between groups with the chi-square test. A value
 0.05 by the two-tailed test was considered statistically
ignificant.
ESULTS
linical characteristics. Study groups were similar in age
nd gender (Table 1). In comparison with group B, group A
atients had higher values of systolic blood pressure (154 
2 mm Hg vs. 147  11 mm Hg, p  0.001), diastolic
lood pressure (95  9 mm Hg vs. 89  8 mm Hg, p 
.001), total cholesterol (210  35 mg/dl vs. 186  40
g/dl, p  0.001), LDL cholesterol (140  36 mg/dl vs.
15  32 mg/dl, p  0.001), and triglycerides (159  80
g/dl vs. 145  82 mg/dl, p  0.001). High-density
ipoprotein cholesterol (55  9 mg/dl vs. 54  15 mg/dl, p
0.069) did not differ significantly between study groups.
ajor risk factors for CAD as defined by the ADA
able 1. Clinical Characteristics of the Study Population
Group A
(n  1,170)
Group B
(n  729) p
ge (yrs) 52.2  7.0 52.0  7.9 0.56
en 67.3 67.9 0.49
MI (kg/m2) 29.2  3.9 29.0  3.5 0.26
bA1c (%) 8.3  1.4 8.2  1.9 0.19
uration of the disease (yrs) 9.3  6.0 9.4  5.0 0.71
ajor risk factors
Current smoking 21.2 4.2 0.001
Previous smoking 36.3 7.6 0.001
Arterial hypertension 69.4 39.2 0.001
Hypercholesterolemia 67.7 21.5 0.001
Family history of premature CAD 28.7 6.4 0.001
Microalbuminuria 37.3 6.4 0.001
ther risk factors
Retinopathy 8.2 8.7 0.82
Peripheral or carotid disease 5.6 2.6 0.001
edications
Beta-blocker 35.0 18.1 0.001
Calcium-channel blockers 25.2 24.8 0.96
ACE inhibitors 64.2 30.5 0.001
ARB 19.4 19.2 0.95
Aspirin 54.5 42.2 0.001
Statins 60.9 14.3 0.001
Insulin 30.1 29.0 0.75
esults are expressed as mean  SD or percentage (%). p values refer to comparisons
etween group A and group B patients.
ACE  angiotensin coenzyme; ARB  angiotensin receptor blocker; BMI 
ody mass index; CAD  coronary artery disease; Hb  hemoglobin.onsensus Statement (17) were more common in group A
t
eatients with DM2. As a consequence, the use of some
edications (beta-blocker, angiotensin-converting enzyme
nhibitors, aspirin, and statins) was more frequent in group
patients. The same percentage of patients in the two
tudy groups used insulin. Body mass index, HbA1c, and the
ncidence of retinopathy were similar, whereas group A
atients had a higher incidence of peripheral or carotid
rtery disease.
BF and coronary angiography. The percentage of dia-
etic patients with abnormal stress-MCE was similar in the
wo study groups with different RF profile (group A, n 
95, 59.4%; group B, n  438, 60.0%). A significant CAD
as present in 449 of 695 (64.6%) of group A and in 287 of
38 (65.5%) in group B patients (p  0.92). Myocardial
lood volume (5.2  1.2 vs. 8.7  1.0, p  0.001), beta
0.34 0.1 vs. 0.78 0.3, p 0.001), and MBF (2.2 1.2
s. 6.9  2.9, p  0.001) were significantly lower during
ipyridamole than at rest in territories with significant
AD. In myocardial segments related to coronary vessels
ith 50% stenosis, MBV was similar during dipyridamole
ompared with rest (8.4  0.9 vs. 8.5  2.0, p  0.14),
hereas beta (1.5  0.5 vs. 0.79  0.4, p  0.001) and
BF (16.2  4.3 vs. 6.5  2.3, p  0.001) increased
ignificantly. Multivariate analysis demonstrated that none
igure 2. (A) Prevalence of one-, two-, or three-vessel coronary artery
isease (CAD) in type 2 diabetes mellitus (DM2) patients with myocardial
erfusion abnormalities at stress myocardial contrast echocardiography and
wo or more associated risk factors (RF) (group A) or no more than one RF
group B). (B) Prevalence of a “diffuse” coronary disease (defined by the
resence of significant stenosis in two or more coronary vessels involving
wo or more segments of each artery) and of total occlusion in at least one
picardial vessel in group A and B patients with DM2.
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January 3, 2006:65–71 CAD in Diabetes Mellitusf the clinical characteristics reported in Table 1 was an
ndependent predictor of significant CAD at coronary
ngiography (smoking, p  0.72; arterial hypertension, p 
.65; hypercholesterolemia, p  0.24; family history of
remature CAD, p  0.45), for BMI (p  0.82), HbA1c (p
0.72), duration of diabetes (p  0.28), retinopathy (p 
.57), and for PVD (p  0.22).
ngiographic characteristics of the coronary vessels and
evascularization procedures. The angiographic charac-
eristics of DM2 patients with abnormal MCE and different
F profiles are illustrated in Figure 2. Although the
revalence of overall significant CAD was similar in both
roups (64.6% vs. 65.5%, p  0.81), in group B, the
ercentages of patients with one-, two- and three-vessel
isease were 70.6%, 21.8%, and 7.6%, respectively, signifi-
antly different from the pattern in group A (46.3%, 20.4%,
nd 33.3%, respectively, chi-square  64.73, p  0.001).
oreover, a larger percentage of group A patients had a
diffuse disease” (54.9% vs. 18.8%, chi-square  93.83 p 
.001) and an occlusion in at least one coronary vessel
31.2% vs. 3.5%, chi-square  82.8, p  0.001).
In addition, no consistent differences emerged between
tudy groups regarding the sites of occluded vessels (LAD:
2.9% vs. 62.0%, p  0.65; LCX: 8.0% vs. 8.9% p  0.79;
ight coronary artery: 31.9% vs. 32.0%, p  0.81).
Angiographic coronary anatomy did not allow any po-
ential revascularization procedures (percutaneous coronary
ntervention [PCI]/coronary artery bypass grafting
CABG]) in 187 (41.6%) group A patients and in 32
11.0%, p  0.001) group B patients. Percutaneous coro-
ary intervention was performed in 178 (39.6%) group A
atients and in 122 (42.5%) group B patients. In coronary
essels treated by PCI, successful revascularization (residual
oronary stenosis 20% and Thrombolysis In Myocardial
nfarction flow grade 3) was obtained in 84% of procedures
erformed in group A and in 91% (p 0.001) of procedures
n group B. Sixty (13.3%) group A and 37 (11.4%) group B
atients underwent CABG. Revascularization of all myo-
ardial areas at risk was obtained in 44 (73.3%) group A
atients and in 36 (97.2%) group B patients (p  0.001).
ISCUSSION
n diabetic patients, the diagnosis of CAD generally is
issed or delayed because the typical symptoms of cardiac
schemia are often masked. As a result, multivessel athero-
clerosis often is present before ischemic symptoms occur
nd before treatment can be instituted (4). A delayed
ecognition of CAD undoubtedly worsens the prognosis for
urvival. Moreover, studies have shown that the absolute
isk for major coronary events in patients with diabetes is
imilar to that of nondiabetic patients with established
AD and that diabetic patients who have not had a
revious myocardial infarction have outcomes similar to
hose of patients without diabetes who have had a prior
yocardial infarction (22). It follows that the combination pf CAD and diabetes mellitus is strongly indicative of
dverse outcome and obliges clinicians to face up to the
roblematic issue of detection of CAD in individuals with
o symptoms who have diabetes mellitus. Effective aggres-
ive strategies for earlier detection of subclinical CAD could
ead to more effective prevention and reduce morbidity and
ortality. In this study, we investigated the prevalence of
yocardial perfusion abnormalities and of CAD in adult
age 60 years) patients with type 2 diabetes.
To assess the role of associated major RFs for CAD,
iabetic patients were divided into two groups with different
F profiles according to the recommendations of the ADA
or test screening. The prevalence of myocardial perfusion
efects and of CAD was similar in the study groups
ndependently of RF profile, suggesting that a substantial
umber of asymptomatic diabetic patients with few RFs
ight have occult CAD. Together with the results of a
ecent study by Wackers et al. (23), these data demonstrate
hat several asymptomatic DM2 patients have myocardial
erfusion abnormalities. The present study completed these
bservations by performing a coronary angiogram and also
howed that the prevalence of significant CAD in patients
ith few RFs was similar to that of patients considered at
igh risk for CAD. These patients might be missed on the
asis of current ADA guidelines (17). In addition, major
Fs (smoking, arterial hypertension, hypercholesterolemia,
amily history of premature CAD, microalbuminuria) as
ell as retinopathy, PVD, HbA1c, and duration of the
isease did not emerge as significant predictors of myocar-
ial perfusion abnormalities or significant CAD. Moreover,
atients with CAD unmasked by an “aggressive” approach
ad a more favorable angiographic anatomy of coronary
essels. These latter patients had a lower prevalence of
hree-vessel disease, “diffuse disease,” and occlusion,
hereas the prevalence of one-vessel disease was higher.
hese results are clinically relevant because angiographic
oronary anatomy dramatically influenced the possibility to
btain adequate myocardial revascularization. Any potential
rocedure was contraindicated by coronary angiographic
ndings in about half of patients assigned to a conventional
pproach but only in a minority of cases in the subgroup in
hom an aggressive approach was used. Moreover, when
evascularization procedures were performed, group B pa-
ients obtained better results: a greater number of coronary
essels were successfully revascularized and, after CABG,
lmost all myocardial areas at risk were reperfused.
The study design of the present clinical investigation does
ot allow the assessment of the actual prevalence of CAD in
symptomatic patients with diabetes mellitus. There is no
ublished large angiographic series of asymptomatic dia-
etic patients to address prevalence of CAD. In the largest
utopsy study of diabetic patients without antemortem
vidence of CAD, approximately 50% of patients65 years
f age and 75% of those 65 years of age had high-grade
oronary atherosclerosis (24). By extrapolation, our series of
atients seems to be representative of these data.
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CAD in Diabetes Mellitus January 3, 2006:65–71Myocardial hypoperfusion in diabetic patients might
esult from pathophysiological factors other than the epi-
ardial coronary narrowing. These factors include small
essel disease, abnormal myocardial capillaries and small
ntramural arteries, endothelial dysfunction, increased plate-
et aggregability, and hyperfibrinogenemia (25–27). Ac-
ording to previous studies with different diagnostic ap-
roaches to detect myocardial ischemia or perfusion defects
uring stress, if coronary angiography is used as the gold
tandard (28–33), there is a subset of diabetic patients with
false positive stress myocardial contrast echocardiographic
tudy. The data presented here contradict this perspective,
uggesting that the diagnostic approaches to detect myocar-
ial perfusion defects might be useful in asymptomatic
iabetic patients with only microvascular disease in a sub-
linical stage. The microcirculation is an important target of
iabetes mellitus, and myocardial perfusion defects might
epresent an early marker for deterioration in microvascular
unction, which plays a role in the pathogenesis of CAD.
he response-to-injury hypothesis of atherosclerosis states
hat the initial damage affects the arterial endothelium,
eading to endothelial dysfunction (34). Thus, myocardial
erfusion defects in asymptomatic patients might represent
n early marker for atherogenic process in the coronary
irculation and might lead to a recommendation for an
ntensified multifactorial treatment approach (35) in these
atients as well.
onclusions and clinical implications. The patient pop-
lation of the present study might be considered represen-
ative of asymptomatic DM2 patients followed in everyday
iabetes practice. The findings of this study suggest that a
ubstantial number of asymptomatic DM2 patients have
yocardial perfusion defects and significant CAD indepen-
ently from RF profile. As a consequence, a large number of
symptomatic DM2 patients with few RFs might have
ccult CAD and might be missed on the basis of current
DA guidelines (14,17). Moreover, patients with 1 RF,
n whom an “aggressive” diagnostic approach was used, have
more favorable angiographic anatomy of coronary vessels.
his might lead to an early aggressive medical treatment of
AD, and the more favorable coronary anatomy has ren-
ered the coronary vessels of these diabetic patients more
menable to interventional treatment. Given the very high
revalence of myocardial perfusion defects and CAD in
M2 patients, this diagnostic approach could be more
ppropriate to the actual clinical decision-making process.
n fact, diabetic patients have a risk for major coronary
vents similar to that of nondiabetic patients with estab-
ished CAD and outcomes, in the absence of a previous
yocardial infarction, similar to those of nondiabetic post-
nfarcted patients. In these latter patient groups, regular and
outine stress testing is already universally considered as a
tandard approach. Contrarily, a high RF profile does not
elp to identify asymptomatic DM2 patients with a higher
revalence of CAD. In the context of DM2 patients with
yocardial perfusion defects, a high RF profile is related tomore severe CAD with an unfavorable angiographic
natomy limiting the possibility to perform a successful and
omplete revascularization by PCI or CABG. A subset of
M2 patients had myocardial perfusion defects in the
bsence of significant stenosis of coronary epicardial vessels,
uggesting the potential to detect patients with only micro-
ascular disease, which might constitute a very early phase of
he atherogenic process in the coronary circulation. Thus, an
ggressive diagnostic approach together with the previously
ecommended intensified multifactorial treatment approach
n diabetic patients (35) has the potential to detect an early
ubclinical phase of the disease and lead to improvement in
utcome of these patients. In 2008, all patients enrolled in
he present study will complete a five-year follow-up,
llowing an explanation of the effects of this diagnostic
pproach on the rate of cardiac events in asymptomatic
M2 patients. Moreover, the follow-up data will provide
nformation for a correct economic analysis of this large-
cale screening strategy.
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